Drug discovery, gene editing, and healthcare innovation from bench to bedside.
Generated July 14, 2026
| # | Ticker | Name | Industry | Stage | C1 | C2 | C3 | C4 | C5 | C6 | C7 | C8 | C9 | Total | Price | 1yr Chg | 30d Target | 90d Ret | Signal | Mkt Cap | TTM EPS | Fwd EPS | EPS Growth | Next Earnings |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | Drug Manufacturers - General | AdvancingMomentum Trend | 5 | 10 | 10 | 10 | 5 | 10 | 10 | 10 | 5 | 75 | $1,188.58 | +51.4% | ▲ $1202.53 | +20.7% | HOLD | $1.1T | $28.17 | $44.82 | +169.9% | 2026-08-05 |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | Biotechnology | AdvancingMomentum Trend | 10 | 5 | 10 | 5 | 10 | 5 | 10 | 10 | 10 | 75 | $485.39 | +1.2% | ▼ $470.25 | +0.2% | WEAK | $123.2B | $16.84 | $21.24 | +61.4% | 2026-08-03 |
| 3 | AMGN | Amgen Inc. | Drug Manufacturers - General | AdvancingMomentum Trend | 0 | 5 | 5 | 10 | 10 | 10 | 10 | 10 | 10 | 70 | $363.39 | +24.6% | ▼ $358.74 | -0.7% | HOLD | $196.1B | $14.35 | $23.45 | +4.4% | 2026-08-04 |
| 4 | NVO | Novo Nordisk A/S | Drug Manufacturers - General | BasingBasing | 0 | 10 | 5 | 10 | 10 | 5 | 10 | 10 | 5 | 65 | $49.48 | -27.0% | ▼ $34.84 | -20.8% | WEAK | $218.9B | $4.17 | $3.25 | +67.1% | 2026-08-05 |
| 5 | ABBV | AbbVie Inc. | Drug Manufacturers - General | AdvancingMomentum Trend | 0 | 10 | 5 | 10 | 10 | 10 | 10 | 5 | 5 | 65 | $248.08 | +31.4% | ▲ $269.89 | +20.2% | HOLD | $438.3B | $2.03 | $16.29 | -46.2% | 2026-07-31 |
| 6 | REGN | Regeneron Pharmaceuticals, Inc. | Biotechnology | DecliningContrarian Setup | 10 | 5 | 5 | 5 | 5 | 5 | 10 | 10 | 10 | 65 | $664.52 | +19.4% | ▼ $650.04 | -14.8% | HOLD | $69.7B | $40.93 | $53.63 | -7.2% | 2026-07-30 |
| 7 | ISRG | Intuitive Surgical, Inc. | Medical Instruments & Supplies | DecliningContrarian Setup | 10 | 10 | 5 | 10 | 5 | 5 | 10 | 5 | 5 | 65 | $406.78 | -22.7% | ▼ $343.99 | -29.6% | WEAK | $144.1B | $8.22 | $11.79 | +18.8% | 2026-07-16⚡ 2d |
| 8 | JNJ | Johnson & Johnson | Drug Manufacturers - General | AdvancingMomentum Trend | 5 | 5 | 5 | 5 | 5 | 10 | 10 | 5 | 5 | 55 | $256.98 | +67.0% | ▲ $284.52 | +24.1% | HOLD | $618.6B | $8.63 | $12.74 | -52.9% | 2026-07-15⚡ 1d |
| 9 | MRNA | Moderna, Inc. | Biotechnology | AdvancingMomentum Trend | 10 | 5 | 0 | 0 | 5 | 5 | 10 | 5 | 10 | 50 | $68.27 | +99.2% | ▼ $59.51 | -10.1% | WEAK | $27.1B | $-8.14 | $-4.15 | — | 2026-07-31 |
| 10 | MDT | Medtronic plc | Medical Devices | DecliningConfirmed Downtrend | 5 | 5 | 10 | 5 | 5 | 5 | 10 | 5 | 0 | 50 | $83.87 | -3.1% | ▼ $80.78 | -3.5% | WEAK | $107.4B | $3.73 | $6.41 | +18.3% | 2026-08-18 |
| # | Ticker | Name | Industry | Stage | C1 | C2 | C3 | C4 | C5 | C6 | C7 | C8 | C9 | Total | Price | 1yr Chg | 30d Target | 90d Ret | Signal | Mkt Cap | TTM EPS | Fwd EPS | EPS Growth | Next Earnings |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | INSM | Insmed Incorporated | Biotechnology | DecliningContrarian Setup | 5 | 5 | 10 | 10 | 10 | 5 | 10 | 5 | 10 | 70 | $115.61 | +19.6% | ▼ $98.51 | -14.2% | WEAK | $25.1B | $-5.76 | $0.12 | — | 2026-08-06 |
| 2 | KYMR | Kymera Therapeutics, Inc. | Biotechnology | AdvancingMomentum Trend | 10 | 5 | 5 | 0 | 10 | 5 | 10 | 5 | 10 | 60 | $119.35 | +164.0% | ▼ $100.96 | -1.9% | WEAK | $9.8B | $-3.58 | $-4.35 | — | 2026-04-30 |
| 3 | DOCS | Doximity, Inc. | Health Information Services | DecliningContrarian Setup | 10 | 5 | 5 | 10 | 0 | 5 | 10 | 5 | 5 | 55 | $21.77 | -63.8% | ▲ $26.34 | +48.1% | HOLD | $4.0B | $0.98 | $1.59 | -69.0% | 2026-08-06 |
| 4 | CRSP | CRISPR Therapeutics AG | Biotechnology | BasingBasing | 10 | 5 | 0 | 0 | 5 | 5 | 10 | 5 | 10 | 50 | $53.35 | -9.6% | ▲ $65.56 | +33.2% | HOLD | $5.3B | $-6.17 | $-3.87 | — | 2026-05-11 |
| 5 | TWST | Twist Bioscience Corporation | Diagnostics & Research | AdvancingMomentum Trend | 5 | 0 | 5 | 5 | 10 | 5 | 10 | 5 | 5 | 50 | $90.64 | +135.6% | ▲ $93.84 | +23.5% | HOLD | $5.6B | $-1.32 | $-0.76 | — | 2026-08-03 |
| 6 | RVMD | Revolution Medicines, Inc. | Biotechnology | AdvancingMomentum Trend | 5 | 5 | 10 | 0 | 10 | 5 | 10 | 5 | 0 | 50 | $186.88 | +385.4% | ▲ $191.89 | +19.4% | HOLD | $39.7B | $-7.10 | $-5.80 | — | 2026-08-05 |
| 7 | NTLA | Intellia Therapeutics, Inc. | Biotechnology | AdvancingMomentum Trend | 10 | 0 | 0 | 0 | 5 | 5 | 10 | 5 | 10 | 45 | $14.21 | +16.9% | ▲ $17.48 | +73.1% | HOLD | $2.0B | $-3.52 | $-1.72 | — | 2026-08-06 |
| 8 | IMVT | Immunovant, Inc. | Biotechnology | AdvancingMomentum Trend | 10 | 5 | 0 | 0 | 10 | 5 | 10 | 5 | 0 | 45 | $39.71 | +126.9% | ▲ $40.99 | +18.0% | HOLD | $8.2B | $-2.77 | $-2.44 | — | 2026-08-10 |
| 9 | BEAM | — | Biotech | Insufficient Data | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 0 | 40 | — | — | ▲ $37.20 | +37.0% | HOLD | — | — | — | — | — |
| 10 | RXRX | Recursion Pharmaceuticals, Inc. | Biotechnology | DecliningContrarian Setup | 10 | 0 | 0 | 0 | 0 | 0 | 10 | 5 | 10 | 35 | $3.56 | -37.7% | ▲ $4.42 | +30.8% | HOLD | $1.9B | $-1.16 | $-0.94 | — | 2026-08-05 |
| 11 | EDIT | Editas Medicine, Inc. | Biotechnology | AdvancingMomentum Trend | 5 | 0 | 0 | 0 | 5 | 0 | 10 | 5 | 10 | 35 | $3.26 | +6.5% | ▲ $3.32 | +17.0% | HOLD | $500M | $-1.14 | $-0.94 | — | 2026-05-05 |
| 12 | HIMS | Hims & Hers Health, Inc. | Drug Manufacturers - Specialty & Generic | ToppingDistribution Risk | 0 | 0 | 0 | 10 | 0 | 5 | 5 | 0 | 0 | 20 | $34.38 | -31.6% | ▼ $24.66 | -48.1% | WEAK | $8.0B | $-0.09 | $0.89 | — | 2026-08-10 |
| # | Ticker | Name | Industry | Stage | C1 | C2 | C3 | C4 | C5 | C6 | C7 | C8 | C9 | Total | Price | 1yr Chg | 30d Target | 90d Ret | Signal | Mkt Cap | TTM EPS | Fwd EPS | EPS Growth | Next Earnings |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETF | Pharma | Insufficient Data | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 0 | 40 | $158.29 | +23.4% | — | — | — | — | — | — | — | — |